To generalize vaccination against meningococci
Eculizumab treatment and impaired opsonophagocytic killing of meningococci
by whole blood from immunized adults.
Neisseria meningitidis contains a polysaccharide capsule, which protects meningococci
against the host immune system and from serum bactericidal activity.
The factors associated with periodic meningococcal outbreaks are not well understood, but they likely include waning population immunity to circulating meningococci
, in conjunction with meningococcal carriage and transmission (6,7).
[Universal vaccination against group-C meningococci
and pneumococci; summary of the advice from the Health Counsil of the Netherlands].
* If vaccinations against Hib, pneumococci, and meningococci
are not included in the national vaccination programs, these vaccinations are recommended for children with rheumatic diseases who have low complement levels or functional asplenia.
The transcription profile of the co-cultured meningococci
was compared to that of meningococci
grown in the same system in the absence of a N.
They are the generic equivalent of sanofi-aventis' Rifadin capsules and are indicated for the treatment of all forms of tuberculosis as well as for the treatment of asymptomatic carriers of neisseria meningitidis to eliminate meningococci
from the nasopharynx.
BioVeris already has licensed from Baxter and others, exclusive rights to commercialize products for possible use in the prevention, diagnosis and treatment of disease caused by Group A streptococci, Group B streptococci, Pneumococci, and Group B meningococci
. The vaccine candidates covered by the new Technology License Agreement are similarly based on a conjugate technology platform and also include recombinant protein antigens.
"Intimate kissing has been shown to be a risk factor for the carriage of meningococci
in university students and it is likely that intimate kissing with multiple partners increases the risk of transmission."
Meningococcal vaccine has also been recommended for those in high-risk groups: those with anatomical or functional asplenia, those with terminal complement component deficiency, laboratory and research personnel with potential exposure to meningococci
, and travelers to areas with endemic meningococcal disease.
A routine vaccination against group C meningococci
was phased in from November 1999.